Aravive News

Company Name Stock Ticker Symbol Market Type
Aravive Inc ARAV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.032 -3.68% 0.837999 11:05:51
Open Price Low Price High Price Close Price Prev Close
0.8502 0.7941 0.8502 0.87
more quote information »

Recent News

Date Time Source Heading
8/11/202210:25TRMNH.C. Wainwright Sticks to Their Buy Rating for Aravive..
8/11/202207:16EDGARCurrent Report Filing (8-k)
8/11/202207:13EDGARQuarterly Report (10-q)
8/11/202207:08EDGARCurrent Report Filing (8-k)
8/11/202207:00GLOBEAravive Reports Second Quarter 2022 Financial Results and..
7/05/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
7/05/202216:06EDGARInitial Statement of Beneficial Ownership (3)
7/05/202209:07GLOBEAravive Appoints Dr. Robert B. Geller as Chief Medical..
7/05/202207:06EDGARCurrent Report Filing (8-k)
6/03/202218:08EDGARStatement of Changes in Beneficial Ownership (4)
6/03/202216:07EDGARCurrent Report Filing (8-k)
6/03/202207:00GLOBEAravive Appoints Rudy Howard as Chief Financial Officer
5/26/202217:27EDGARCurrent Report Filing (8-k)
5/26/202217:11GLOBEAravive Presents Updated Clinical Data at ASCO Showing..
5/17/202207:00GLOBEAravive to Participate in H.C. Wainwright Global Investment..
5/12/202207:12EDGARQuarterly Report (10-q)
5/12/202207:00GLOBEAravive Reports First Quarter 2022 Financial Results and..
5/12/202206:16TRMNH.C. Wainwright Thinks Aravive’s Stock is Going to Recover
5/05/202207:00GLOBEAravive to Host Key Opinion Leader Symposium on May 11, 2022
4/29/202207:00GLOBEAravive Announces Poster Presentations at the 2022 ASCO..
4/05/202216:16EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
4/04/202216:19EDGARStatement of Changes in Beneficial Ownership (4)
4/04/202216:18EDGARCurrent Report Filing (8-k)
4/01/202207:00GLOBEAravive Announces Closing of $10 Million Registered Direct..
3/31/202216:55SEEKAravive GAAP EPS of -$0.62 misses by $0.02, revenue of..
3/31/202216:18EDGARStatement of Changes in Beneficial Ownership (4)
3/31/202216:12EDGARCurrent Report Filing (8-k)
3/31/202216:05GLOBEAravive Reports Fourth Quarter and Full Year 2021 Financial..
3/31/202215:02EDGARAnnual Report (10-k)
3/30/202208:12SEEKAravive launches ~$10M stock and warrant offering
3/30/202208:00GLOBEAravive Announces $10 Million Registered Direct Offering..
3/25/202216:10EDGARCurrent Report Filing (8-k)
3/22/202217:39EDGARStatement of Changes in Beneficial Ownership (4)
3/22/202217:38EDGARInitial Statement of Beneficial Ownership (3)
3/22/202216:07EDGARCurrent Report Filing (8-k)
3/22/202207:13SEEKAravive names Scott Dove, Ph.D., as COO
3/22/202207:00GLOBEAravive Appoints Scott Dove, Ph.D., as Chief Operating..
3/21/202216:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/21/202216:06EDGARCurrent Report Filing (8-k)
3/19/202205:08TRMNAravive (ARAV) Gets a Buy Rating from BTIG
3/07/202207:00GLOBEAravive to Participate In-Person at 34th Annual ROTH..
3/03/202207:07EDGARCurrent Report Filing (8-k)
3/03/202207:00GLOBEAravive Announces Positive Updated Data and New Biomarker..
3/02/202207:00GLOBEAravive to Present Updated Modeling Data from Batiraxcept..
2/11/202217:11EDGARProxy Statement (definitive) (def 14a)
1/31/202209:19SEEKAravive begins dosing in phase 2 study of batiraxcept to..
1/31/202207:06EDGARCurrent Report Filing (8-k)
1/31/202207:00GLOBEAravive Announces First Patient Dosed in Phase 2 Study of..
1/25/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
1/25/202216:06EDGARStatement of Changes in Beneficial Ownership (4)

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now